Scotts Miracle-Gro

Scotts Miracle-Gro Co. engages in the manufacturing, marketing, and sale of products for lawn and garden care and indoor and hydroponic gardening. Its products and services include lawn care, gardening and landscape, hydroponic hardware and growing environments, lighting, controls, and marketing agreement. It operates through the following segments: U.S. Consumer, Hawthorne, and Other. The U.S. Consumer and Other segments manufacture and market branded consumer lawn and garden products. The U.S. Consumer segment consists of consumer lawn and garden business in the United States. The Hawthorne segment manufactures, markets, and distributes lighting, nutrients, growing media, growing environments, and hardware products for indoor and hydroponic gardening in North America. The company was founded by Orlando McLean Scott in 1868 and is headquartered in Marysville, OH.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Scotts Miracle-Gro exceeds Q1 sales goal, eyes cannabis growth

Scotts Miracle-Gro (SMG) reported strong Q1 performance, exceeding sales goals and achieving profitability milestones.
Despite challenges in the Hawthorne segment, the company remains optimistic about growth opportunities in the cannabis sector.
Commitment to disciplined growth strategies, pricing strength, and leveraging free cash flow for debt repayment and potential reinvestment.
Focus on consumer engagement, market recovery, and maintaining liquidity to drive future success.

Scotts Miracle-Gro reports strong Q2 performance amidst industry challenges

Scotts Miracle-Gro (SMG) reported strong Q2 performance in the US Consumer business, with cost reductions and efficiency gains contributing to improved free cash flow.
While facing challenges in the Hawthorne segment, the company remains focused on reaching breakeven and aligning with the cannabis market's realities for improved performance.
Opportunities lie in positive industry developments, potential pricing adjustments, strategic partnerships in the cannabis market, and value creation initiatives.
Despite margin hindrances, Scotts Miracle-Gro (SMG) is optimistic about the season's progress and committed to growth strategies and profitability through innovation and partnerships.

Scotts Miracle-Gro faces challenges but eyes growth opportunities in 2024

Scotts Miracle-Gro faced challenges in meeting its targets but saw growth in consumer retail sales, with a focus on debt reduction and maintaining dividend payments.
The company is on track with its debt reduction plan, aiming for $1 billion over 2 years, and is exploring opportunities for margin accretion and partnerships for future growth.
Despite short-term financial challenges, Scotts Miracle-Gro is implementing cost-saving measures, focusing on broadening retailer relationships, and anticipating a return to $600 million EBITDA next year.
The Hawthorne business is stabilizing, aiming for profitability, exploring partnerships, and considering strategic actions to address industry challenges, while maintaining a commitment to debt reduction.

Scotts Miracle-Gro reports fiscal '23 improvements, eyes growth in '24

Scotts Miracle-Gro's fiscal '23 performance showcased financial discipline and operational improvements despite sales challenges, setting the stage for growth in fiscal '24.
The company's focus on core consumer, marketing, innovation, and strategic solutions positions it well to capitalize on opportunities for revenue growth and margin enhancement.
While facing challenges such as sales declines and margin pressures, Scotts Miracle-Gro's strategic outlook for fiscal '24 emphasizes growth, profitability, and operational efficiency.
By addressing concerns, leveraging data analytics, and enhancing marketing efforts, Scotts Miracle-Gro aims to drive performance and shareholder value in the upcoming year.

Scotts Miracle-Gro reports strong Q1 results, focuses on profitability

Scotts Miracle-Gro's Q1 performance reflects positive growth and margin improvement strategies.
The company is focused on profitability, leveraging strengths in North America and retail partnerships.
Challenges include managing leverage, transitioning Hawthorne to profitability, and SG&A adjustments.
Opportunities lie in volume growth, partnerships, and sustainable reinvestment for future growth.

Scotts Miracle-Gro surpasses financial targets and navigates industry challenges

Scotts Miracle-Gro delivered strong financial performance, exceeding targets and showcasing growth in consumer business. The focus on proprietary brands, partnerships, and cost optimization reflects a commitment to long-term success.
Challenges include pending deals, achieving profitability in Hawthorne, and navigating the evolving cannabis industry landscape. Opportunities in advertising, strategic partnerships, and cost optimization pave the way for future growth.
Overall, Scotts Miracle-Gro's Q2 earnings call highlighted solid performance, strategic initiatives, and a positive outlook for future sales growth. Management's focus on financial metrics, consumer engagement, and profitability sets a strong foundation for continued success.

Scotts Miracle-Gro reports strong Q3 performance and strategic growth focus

Scotts Miracle-Gro delivered a robust performance in Q3 2024, showcasing growth in net sales, profitability, and market share across its key divisions, driven by strategic initiatives and operational efficiencies.
While facing challenges related to increased SG&A expenses and market dynamics, the company's focus on debt reduction, margin improvement, and financial discipline positions it well for long-term success and sustainable growth.
With opportunities to capitalize on its strong market position, drive innovation, and optimize pricing strategies, Scotts Miracle-Gro is poised to navigate challenges and leverage growth prospects for enhanced shareholder value.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

AFC Gamma

Innovative Industrial Properties

Ancillary Pot Stocks To Watch Before July The post Best Ancillary Marijuana Stocks While The Market Is Down? 3 To Watch Long Term appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Best Ancillary Marijuana Stocks While The Market Is Down? 3 To Watch Long Term

Aurora Cannabis

Canopy Growth

Amplify Seymour Cannabis ETF

Cronos Group

Curaleaf Holdings, Inc.

GrowGeneration Corp

Hydrofarm Holdings Group

Amplify Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

NewLake Capital Partners, Inc.

Global X Cannabis ETF

Power REIT

Chicago Atlantic Real Estate Finance

Trulieve Cannabis Corp.

Tilray Brands

Cambria Cannabis ETF

Village Farms International

AdvisorShares Pure Cannabis ETF 

Cannabis REITs - a perennial performance leader over the past half-decade - have been slammed in 2022 amid concerns over tenant financial health given the sharp re-pricing of risk and tighter financial conditions. Owning the "Pharmland" - the physical real estate - had been one of the few cannabis plays that was working amid a decade-long stretch of dismal investment performance from broader cannabis ETFs.

Cannabis REITs: Weeding Out The Weak

Green Thumb Industries Inc.

In theory, it could, but the cannabis industry will still be growing like weeds regardless.

Will Inflation Stunt This Growth Industry?

AbbVie

Jazz Pharmaceuticals

Top Marijuana Stocks To Watch For More Momentum In June The post 3 Marijuana Stocks That May See A Turnaround In Trading This Month appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

3 Marijuana Stocks That May See A Turnaround In Trading This Month

MARYSVILLE, Ohio, June 13, 2022 (GLOBE NEWSWIRE) -- The Scotts Miracle-Gro Company (NYSE: SMG), one of the world's leading marketers of branded consumer lawn and garden as well as hydroponic and indoor growing products, announced today that The Honorable Brian Sandoval has been named to its Board of Directors.

ScottsMiracle-Gro Announces the Appointment of Governor Brian Sandoval to its Board of Directors

The Scotts Miracle-Gro Company (NYSE: SMG) dropped 15% after the leader in the marketing of branded consumer garden, and lawn products stated that consumer sales of its lead garden and lawn brands surged in May as unit volume trends towards the firm's original guidance for the season. Despite the increase in purchases, the company said […] The post Here is why The Scotts Miracle-Gro Company dipped 15% appeared first on Invezz.

Here is why The Scotts Miracle-Gro Company dipped 15%

Clever Leaves Holdings Inc

High Tide

InMed Pharmaceuticals

Neptune Wellness Solutions Inc.

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks this week, and look ahead to how the cannabis industry will continue to develop in 2022.

This Week's Cannabis Stock News: 7 Companies Make Headlines

The stock is a holding in 119 ETFs, with cannabis funds offering the most exposure.

Scotts Miracle-Gro Down 10% On Profit Warning

ScottsMiracle-Gro's (SMG) adjusted earnings per share are now projected between $4.50 to $5.

ScottsMiracle-Gro (SMG) Lowers Sales and EPS Outlook for FY22

Are Ancillary Pot Stocks A Good Long Term Investment In Cannabis? The post Best Cannabis Stocks To Buy? 3 To Watch Long Term In June appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Best Cannabis Stocks To Buy? 3 To Watch Long Term In June

Scotts Miracle-Gro cut its sales and earnings guidance for the year, despite strong consumer retail sales.

Why Scotts Miracle-Gro Stock Is Wilting Today

The Scotts Miracle-Gro Company (NYSE: SMG) shares are trading lower after the company cut its FY22 EPS guidance below analyst estimates.  The company now expects 2022 earnings per share to be between $4.50 and $5.00 versus the consensus estimate of $7.01.

Why Scotts Miracle-Gro Company Shares Are Falling

Shares of Scotts Miracle-Gro fell 13% in premarket trading Wednesday, after the maker of lawn and garden care products lowered its 2022 guidance for both profit and sales.

Scotts Miracle-Gro Stock Falls on Weak Guidance

Corteva Inc

Roku

With U.S. stock markets set to open in two hours, Corteva (CTVA) was up 10.1% in pre-market trading, and Roku Cl A (ROKU) was up 6.4%. DocuSign (DOCU), Western Digital (WDC), and Campbell Soup (CPB) were all posting gains of at least 4%.

Premarket Movers: Scotts Miracle-Gro, Corteva, Roku Cl A

Scotts Miracle-Gro Co. SMG, +2.07% shares fell 12% in premarket trades Wednesday after the lawn and garden specialist said it now expects 2022 adjusted earnings of $4.50 a share to $5 a share, below the current analyst target of $6.95 a share in a survey by FactSet. U.S. consumer sales are expected to decline by 4% to 6%.

Scotts Miracle-Gro shares drop on profit warning

MARYSVILLE, Ohio, June 08, 2022 (GLOBE NEWSWIRE) -- The Scotts Miracle-Gro Company (NYSE: SMG), the world's leading marketer of branded consumer lawn and garden as well as indoor and hydroponic growing products, said consumer purchases of its core lawn and garden brands surged in May with unit volume now trending towards the Company's original assumptions for the season. However, a variety of factors prompted the Company to lower its outlook for both sales and adjusted earnings for fiscal 2022.

ScottsMiracle-Gro Reduces Outlook for Sales and Non-GAAP Adjusted EPS Despite Strong Recovery in Consumer Lawn & Garden Participation

Scotts (SMG) reported earnings 30 days ago. What's next for the stock?

Why Is Scotts (SMG) Down 21% Since Last Earnings Report?

3 Marijuana Stocks To Watch This Month The post The Best Marijuana Stocks To Buy The First Week Of June? appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

The Best Marijuana Stocks To Buy The First Week Of June?

The US cannabis industry is flush with fledgling companies and many unfamiliar brands.

How Scotts Miracle-Gro is reinventing itself as one of the biggest players in cannabis

Best Ancillary Cannabis Stocks Making A Move This Week The post 3 Top Ancillary Marijuana Stocks For 2022 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

3 Top Ancillary Marijuana Stocks For 2022

They're stable enough to keep paying a meaty dividend for years.

Want Passive Income? These 2 Stocks Are Paying Out

Are Top Ancillary Pot Stocks A Buy In May? The post Best Ancillary Marijuana Stocks To Buy? 2 For Your List Right Now While The Market Is Down appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Best Ancillary Marijuana Stocks To Buy? 2 For Your List Right Now While The Market Is Down

Flora Growth Corp

HEXO Corp

WM Technology

22nd Century Group

10 Marijuana Stocks Lighting Up With a Focus on Earnings

Scotts Miracle-Gro's (SMG) Q2 results are impacted by lower sales and profits in the Hawthorne segment.

Scotts Miracle-Gro (SMG) Earnings and Sales Beat Estimates in Q2

"While Scotts Miracle-Gro might seem cheap on a price to earnings basis ... management doesn't have a handle on how bad it's going to get," the "Mad Money" host said.

Here's why Jim Cramer is warning investors to stay away from Scotts Miracle-Gro

News for Scotts Miracle-Gro Stock (SMG)